Exchange: NASDAQ·Updated 09:50 PM EDT

IOVA Earnings

Latest Earnings Results: Q2 '26

Reported: Aug 06

Estimated EPS

-$0.12

Reported EPS

-$0.11

Surprise

+7.65%

Estimated Rev

$92.34M

Reported Rev

$99.31M

Surprise

+7.56%

• Reported GAAP EPS of -$0.11 up 66.67% YoY • Reported revenue of $198.63M up 231.31% YoY • Iovance Biotherapeutics is reviewing its previously issued 2026 total revenue guidance of $350 million to $370 million based on strong second-quarter sales and current demand trends, with an update expected later.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.09
--
--
N/A
Q2 '26
-$0.12
-$0.11
7.65%
BEAT
Q1 '26
-$0.15
-$0.19
-23.68%
MISSED
Q4 '25
-$0.17
-$0.18
-2.90%
MISSED
Q3 '25
-$0.26
-$0.25
2.98%
BEAT

Advertisement|Remove ads.